Status:
COMPLETED
SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES
Lead Sponsor:
Ministerio de Salud de Ciudad Autónoma de Buenos Aires
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The pandemic of a new coronavirus SARS-COV-2, which causes COVID-19 disease, has spread rapidly and is a major public health challenge. While the focus is primarily on containing the number of cases a...
Eligibility Criteria
Inclusion
- Age ≥18 at the time of signing the informed consent
Exclusion
- ≤17 years old.
- Declare that currently having confirmed COVID-19 infection.
- Inability to give informed consent
Key Trial Info
Start Date :
August 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 22 2020
Estimated Enrollment :
5900 Patients enrolled
Trial Details
Trial ID
NCT04482361
Start Date
August 6 2020
End Date
December 22 2020
Last Update
January 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministerio de Salud de la Ciudad Autónoma de Buenos Aires
Buenos Aires, Argentina, 1284